Analyst Ratings for Ventyx Biosciences
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on Ventyx Biosciences (NASDAQ:VTYX) stock. The analysts have an average price target of $58.25 versus the current price of Ventyx Biosciences at $38.835, implying upside. The average price target has increased by 0.43% over the past month.
July 05, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts predict an upside for Ventyx Biosciences with an average price target of $58.25, which is higher than the current price of $38.835. The average price target has increased by 0.43% over the past month.
The analysts' average price target for Ventyx Biosciences is significantly higher than its current price, indicating a potential upside. This is likely to have a positive impact on the stock price in the short term. The increase in the average price target over the past month also suggests growing confidence among analysts about the stock's prospects.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100